We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Blood Biomarker Protein Correlates with Severity of Brain Damage in Stroke Patients

By LabMedica International staff writers
Posted on 23 Nov 2020
Print article
Image: A clot in the neck or brain can lead to a stroke (Photo courtesy of Mayo Clinic)
Image: A clot in the neck or brain can lead to a stroke (Photo courtesy of Mayo Clinic)
Researchers have identified a stroke-related biomarker protein that correlates with the severity of brain tissue damage as well as with functional outcome and mortality.

The outcome of a stroke varies greatly between patients from temporary mild symptoms to permanent disability and death. As the currently used clinical scale for measuring disease severity shows poor correlation with brain tissue damage, it is necessary to identify better markers of tissue damage, which could improve the ability to predict outcome and promote the development of better therapies.

In this regard, investigators at the Mayo Clinic (Jacksonville, FL, USA) examined whether the blood protein neurofilament light (NFL) would fulfill this purpose for stroke patients with acute cerebral infarction (ACI), aneurysmal subarachnoid hemorrhage (SAH), or nontraumatic intracerebral hemorrhage (ICH).

Neurofilament light (NFL) is a neurofilament protein that in humans is encoded by the NEFL gene. NFL is a biomarker that can be measured with immunoassays in cerebrospinal fluid and plasma and reflects axonal damage in a wide variety of neurological disorders. It is a useful marker for disease monitoring in amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's disease, and more recently Huntington's disease.

For the current study, the investigators measured NFL concentrations in blood collected from 314 stroke patients and in blood from 79 healthy individuals. Results revealed that compared to healthy individuals NFL was higher for all stroke types. NFL associated with radiographic markers of brain tissue damage and correlated with the extent of early ischemic injury in patients with ACI, hemorrhage severity in patients with SAH, and intracranial hemorrhage volume in patients with ICH. Furthermore, higher NFL concentrations independently associated with three- or six-month functional disability and higher all-cause mortality.

"We discovered that blood levels of NFL do predict stroke severity," said senior author Dr. Leonard Petrucelli, professor of neuroscience at the Mayo Clinic. "We found that higher NFL levels forecast worse functional outcomes and shorter survival time after a stroke. We found this to be the case for ischemic stroke and hemorrhagic strokes. Our study establishes NFL as a promising prognostic biomarker for stroke."

The study was published in the November 11, 2020, online edition of the journal Science Translational Medicine.

Related Links:
Mayo Clinic

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.